一个控制释放微芯片
J T Santini1, M J Cima, R Langer
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. rlanger@mid.edu
Nature
|February 13, 1999
概括
研究人员开发了一种新的微芯片,用于按需,脉动性药物输送. 这种固态装置使用电化学溶解来控制各种化学物质的释放.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 药物输送系统 药物输送系统
背景情况:
- 传统的药物输送通常依赖于对外部刺激做出反应的聚合物材料.
- 微型制造为创建具有精确流体控制的活跃设备提供了替代方案.
研究的目的:
- 引入一种新的固态微芯片,用于对化学物质的控制,按需释放.
- 展示一种实现脉动性药物释放的新机制.
主要方法:
- 开发一个带有含有化学物质的微储存器的微芯片.
- 使用薄阳极膜的电化学溶解作为释放机制.
- 使用黄金和盐溶液作为模型材料的原理证明研究.
主要成果:
- 从微芯片中释放出化学物质的可控,脉动式释放.
- 成功实施了电化学溶解来触发物质释放.
- 验证了微芯片传递单个或多个化学物质的能力.
结论:
- 开发的微芯片为按需,可控脉动药物输送提供了一个有前途的平台.
- 电化学溶解为精确控制化学物质释放提供了一个可行的机制.
- 这项技术在先进的治疗输送系统中具有潜在的应用.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...


